The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Eliem Therapeutics, Inc(NASDAQ:ELYM)


Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems in the United States. The compan...
Website: http://www.eliemtx.com
Founded: 2018
CEO: Bob Azelby
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Eliem Therapeutics Op Cashflow Per Share ttm
Eliem Therapeutics Free Cashflow Per Share ttm
Eliem Therapeutics Cash Per Share ttm
Eliem Therapeutics (GAAP) P/E ratio ttm
Eliem Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.